ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Lyra Pharma Limited

Lyra Pharma Limited is an active company incorporated on 16 November 2021 with the registered office located in London, City of London. Lyra Pharma Limited was registered 3 years ago.
Status
Active
Active since incorporation
Company No
13747076
Private limited company
Age
3 years
Incorporated 16 November 2021
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Due Soon
Dated 15 November 2024 (11 months ago)
Next confirmation dated 15 November 2025
Due by 29 November 2025 (27 days remaining)
Last change occurred 2 years 11 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (11 months remaining)
Address
Cannon Place
78 Cannon Street
London
EC4N 6AF
United Kingdom
Same address since incorporation
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
3
Shareholders
4
Controllers (PSC)
1
PSC • Director • Canadian,british • Lives in Canada • Born in Mar 1960
Director • British • Lives in UK • Born in Mar 1968
Director • Canadian • Lives in United States • Born in Feb 1981
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
APHL 3 Limited
Graham Julian Fraser-Pye is a mutual person.
Active
Iorek Pharma Limited
Graham Julian Fraser-Pye is a mutual person.
Active
Rodio Pharma Limited
Graham Julian Fraser-Pye is a mutual person.
Active
Stark Pharmaceuticals Limited
Graham Julian Fraser-Pye is a mutual person.
Active
Coram Pharma Limited
Graham Julian Fraser-Pye is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2022–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£173.27K
Decreased by £585.03K (-77%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£189.17K
Decreased by £765.36K (-80%)
Total Liabilities
-£503.92K
Decreased by £725.69K (-59%)
Net Assets
-£314.75K
Decreased by £39.68K (+14%)
Debt Ratio (%)
266%
Increased by 137.57% (+107%)
Latest Activity
Full Accounts Submitted
1 Month Ago on 26 Sep 2025
Confirmation Submitted
11 Months Ago on 28 Nov 2024
Mr Graham Julian Fraser-Pye Details Changed
11 Months Ago on 15 Nov 2024
Ian Jacobson Details Changed
11 Months Ago on 15 Nov 2024
Mr Craig Podolsky Details Changed
11 Months Ago on 15 Nov 2024
Mr Ian Jacobson (PSC) Details Changed
11 Months Ago on 15 Nov 2024
Full Accounts Submitted
1 Year 1 Month Ago on 30 Sep 2024
Mr Craig Podolsky Details Changed
1 Year 7 Months Ago on 8 Mar 2024
Confirmation Submitted
1 Year 11 Months Ago on 16 Nov 2023
Mr Graham Julius Fraser-Pye Details Changed
3 Years Ago on 7 May 2022
Get Credit Report
Discover Lyra Pharma Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Total exemption full accounts made up to 31 December 2024
Submitted on 26 Sep 2025
Statement of capital following an allotment of shares on 31 December 2024
Submitted on 2 Jan 2025
Confirmation statement made on 15 November 2024 with no updates
Submitted on 28 Nov 2024
Director's details changed for Mr Graham Julian Fraser-Pye on 15 November 2024
Submitted on 26 Nov 2024
Change of details for Mr Ian Jacobson as a person with significant control on 15 November 2024
Submitted on 25 Nov 2024
Director's details changed for Mr Craig Podolsky on 15 November 2024
Submitted on 25 Nov 2024
Director's details changed for Ian Jacobson on 15 November 2024
Submitted on 25 Nov 2024
Total exemption full accounts made up to 31 December 2023
Submitted on 30 Sep 2024
Director's details changed for Mr Craig Podolsky on 8 March 2024
Submitted on 27 Aug 2024
Director's details changed for Mr Graham Julius Fraser-Pye on 7 May 2022
Submitted on 27 Aug 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year